Learn More
Cayman Chemical AldoxorubIcInhydrochLRIde 10mg

Supplier: Cayman Chemical 3531110 MG
A prodrug form of doxorubicin; selectively binds to serum albumin, which releases doxorubicin in acidic environments, such as the tumor microenvironment; inhibits the proliferation of RenCa, MCF-7, and LXFL 529 cells (IC50s = 1, 1.1, and 0.5 µM, respectively); induces tumor regression in an MDA-MB-435 breast cancer mouse xenograft model at 39.3 µmol/kg; not toxic to mice unlike doxorubicin (LD50 = >60 mg/kg); has been used to conjugate doxorubicin to antibodies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.